CUSIP: 00211Y506
What is CUSIP 00211Y506?
CUSIP 00211Y506 identifies ABIO - ARCA BIOPHARMA INC - COM in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 00211Y506:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2024 Q3 | 0 | $0 | -$48,471,933 | 0 | |
| 2024 Q2 | 12,920,004 | $49,421,425 | +$26,259,435 | $3.83 | 30 |
| 2024 Q1 | 7,198,831 | $12,675,194 | -$473,563 | $1.76 | 21 |
| 2023 Q4 | 7,477,164 | $12,710,802 | +$357,728 | $1.70 | 23 |
| 2023 Q3 | 3,257,695 | $6,547,898 | +$923,112 | $2.01 | 20 |
| 2023 Q2 | 2,830,358 | $5,745,277 | +$631,266 | $2.03 | 22 |
| 2023 Q1 | 2,523,031 | $5,015,761 | -$187,741 | $1.99 | 25 |
| 2022 Q4 | 2,614,171 | $6,185,189 | -$935,435 | $2.36 | 21 |
| 2022 Q3 | 2,222,131 | $4,577,378 | +$1,085,096 | $2.06 | 21 |
| 2022 Q2 | 1,675,731 | $4,173,211 | +$1,359,311 | $2.49 | 21 |
| 2022 Q1 | 1,132,828 | $2,603,860 | +$47,546 | $2.30 | 19 |
| 2021 Q4 | 1,120,678 | $2,408,886 | -$1,261,277 | $2.15 | 16 |
| 2021 Q3 | 1,528,270 | $4,525,000 | +$976,704 | $2.96 | 15 |
| 2021 Q2 | 1,192,651 | $4,162,000 | +$1,088,178 | $3.49 | 12 |
| 2021 Q1 | 876,401 | $3,197,000 | +$109,482 | $3.65 | 14 |
| 2020 Q4 | 820,991 | $3,291,000 | +$1,624,795 | $4.00 | 15 |
| 2020 Q3 | 411,669 | $1,818,000 | +$1,174,018 | $4.41 | 8 |
| 2020 Q2 | 135,652 | $898,000 | -$420,362 | $6.62 | 3 |
| 2020 Q1 | 200,838 | $561,000 | -$64,031 | $2.81 | 5 |
| 2019 Q4 | 210,936 | $1,203,000 | +$237,558 | $5.69 | 6 |
| 2019 Q3 | 170,148 | $909,000 | -$771,008 | $5.35 | 6 |
| 2019 Q2 | 272,431 | $1,956,000 | +$1,956,000 | $7.32 | 7 |